Bart Yossi, Fishel Bartal Michal, Plaschkes Roni, Sebag Diklah, Chauhan Suneet P, Sibai Baha M, Meyer Raanan, Kassif Eran, Yoeli Rakefet, Mazaki-Tovi Shali
Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
Am J Perinatol. 2024 May;41(S 01):e1397-e1403. doi: 10.1055/a-2028-7633. Epub 2023 Feb 6.
This study aimed to ascertain the outcomes associated with a cervical cerclage among individuals with a history of previable prelabor rupture of membranes (PROM).
This study was a retrospective cohort study conducted at a single tertiary center between 2011 and 2021. We included individuals with a history of previable (before 24 weeks) PROM and the subsequent viable pregnancy. Women with multifetal gestation, preterm birth (PTB) or cerclage in previous gestation, or abdominal cerclage after trachelectomy were excluded. Primary outcome was PTB rate (delivery <37 weeks). Recurrence of preterm PROM and adverse composite maternal and neonatal outcomes (CMO and CNO) were evaluated as secondary outcomes. CMO included any of the following: suspected chorioamnionitis, endometritis, red blood cell transfusion, uterine rupture, unplanned hysterectomy, or death. CNO included any of the following: previable PTB (<24 weeks of gestation), bronchopulmonary dysplasia, grade 3 or 4 intraventricular hemorrhage, necrotizing enterocolitis, mechanical ventilation, seizures, hypoxic ischemic encephalopathy, or death.
During the study period, 118 individuals had a history of previable PROM and a documented subsequent pregnancy, out of which 74 (62.7%) met inclusion criteria. Nineteen (25.7%) of eligible individuals underwent a cerclage for prior previable PROM and were compared with controls ( = 55, 74.3%). Women who underwent a cerclage had higher rates of PTB < 37 weeks (63.2 vs. 10.9%, < 0.001; odds ratio [OR]: 14.00, 95% confidence interval [CI]: 3.97-49.35) and < 34 weeks (21.1 vs. 3.6%, = 0.03; OR: 7.07, 95% CI: 1.18-42.39) compared with those without cerclage. Furthermore, recurrent preterm PROM and previable PTB rates were higher among patients who underwent cerclage. The survival curve further indicated that individuals with cerclage delivered earlier. CMO and CNO rates were similar in those with and without cerclage.
Cerclage placement in individuals with prior previable PROM was associated with higher rates of recurrent preterm PROM and PTB.
· The management of individuals in a subsequent pregnancy following previable PROM is a conundrum.. · Cerclage following previable PROM is associated with higher rates of recurrent preterm PROM and PTB.. · Composite maternal and neonatal outcome rates were similar in those with and without cerclage..
本研究旨在确定既往有未足月胎膜早破(PROM)史的患者行宫颈环扎术的结局。
本研究是一项回顾性队列研究,于2011年至2021年在一家单一的三级中心进行。我们纳入了有未足月(24周前)PROM史及随后活产妊娠的患者。排除多胎妊娠、既往妊娠有早产(PTB)或宫颈环扎史,或子宫切除术后行腹式宫颈环扎术的女性。主要结局是PTB发生率(分娩孕周<37周)。复发性早产PROM以及不良孕产妇和新生儿复合结局(CMO和CNO)被评估为次要结局。CMO包括以下任何一项:疑似绒毛膜羊膜炎、子宫内膜炎、红细胞输血、子宫破裂、计划外子宫切除术或死亡。CNO包括以下任何一项:未足月PTB(妊娠<24周)、支气管肺发育不良、3级或4级脑室内出血、坏死性小肠结肠炎、机械通气、癫痫发作、缺氧缺血性脑病或死亡。
在研究期间,118例患者有未足月PROM史且有记录的后续妊娠,其中74例(62.7%)符合纳入标准。19例(25.7%)符合条件的患者因既往未足月PROM接受了宫颈环扎术,并与对照组(n = 55,74.3%)进行比较。接受宫颈环扎术的女性<37周PTB发生率更高(63.2%对10.9%,P<0.001;比值比[OR]:14.00,95%置信区间[CI]:3.97 - 49.35),<34周PTB发生率也更高(21.1%对3.6%,P = 0.03;OR:7.07,95%CI:1.18 - 42.39),与未接受宫颈环扎术的女性相比。此外,接受宫颈环扎术的患者复发性早产PROM和未足月PTB发生率更高。生存曲线进一步表明接受宫颈环扎术的患者分娩更早。有和没有宫颈环扎术的患者CMO和CNO发生率相似。
既往有未足月PROM的患者行宫颈环扎术与复发性早产PROM和PTB发生率较高相关。
·既往有未足月PROM的患者后续妊娠的管理是一个难题。·未足月PROM后行宫颈环扎术与复发性早产PROM和PTB发生率较高相关。·有和没有宫颈环扎术的患者孕产妇和新生儿复合结局发生率相似。